BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22760715)

  • 1. Incremental cost of nosocomial bacteremia according to the focus of infection and antibiotic sensitivity of the causative microorganism in a university hospital.
    Riu M; Chiarello P; Terradas R; Sala M; Garcia-Alzorriz E; Castells X; Grau S; Cots F
    Medicine (Baltimore); 2017 Apr; 96(17):e6645. PubMed ID: 28445264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight on antimicrobial therapy adjustment strategies for gram-negative bacterial infection: A cohort study.
    Du W; Chen H; Xiao S; Tang W; Shi G
    Medicine (Baltimore); 2017 Mar; 96(13):e6439. PubMed ID: 28353572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammaging in Multidrug-Resistant Sepsis of Geriatric ICU Patients and Healthcare Challenges.
    Kumar NR; Balraj TA; Shivashankar KK; Jayaram TC; Prashant A
    Geriatrics (Basel); 2024 Apr; 9(2):. PubMed ID: 38667512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.
    Tansarli GS; Karageorgopoulos DE; Kapaskelis A; Falagas ME
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):321-31. PubMed ID: 23458771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, antimicrobial resistance and mortality of
    Xiao S; Liang X; Han L; Zhao S
    Front Public Health; 2023; 11():1294141. PubMed ID: 38249405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy.
    Hillock NT; Merlin TL; Turnidge J; Karnon J
    Appl Health Econ Health Policy; 2022 Jul; 20(4):479-486. PubMed ID: 35368230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of blaOXA-181-positive isolates in patients admitted to two major hospital intensive care units in Kuwait.
    Al Fadhli AH; Jamal WY; Rotimi VO
    PLoS One; 2020; 15(11):e0241971. PubMed ID: 33201906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
    Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA
    Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB).
    Cai Y; Chua NG; Lim TP; Teo JQ; Lee W; Kurup A; Koh TH; Tan TT; Kwa AL
    PLoS One; 2016; 11(7):e0158740. PubMed ID: 27441603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis.
    Raman G; Avendano E; Berger S; Menon V
    BMC Infect Dis; 2015 Sep; 15():395. PubMed ID: 26423743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore.
    Ling ML; Tee YM; Tan SG; Amin IM; How KB; Tan KY; Lee LC
    Antimicrob Resist Infect Control; 2015; 4():26. PubMed ID: 26106476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control study.
    Vasudevan A; Memon BI; Mukhopadhyay A; Li J; Tambyah PA
    Antimicrob Resist Infect Control; 2015; 4(1):3. PubMed ID: 25653851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The excess financial burden of multidrug resistance in severe gram-negative infections in Singaporean hospitals.
    Ng E; Earnest A; Lye DC; Ling ML; Ding Y; Hsu LY
    Ann Acad Med Singap; 2012 May; 41(5):189-93. PubMed ID: 22760715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study.
    Lye DC; Earnest A; Ling ML; Lee TE; Yong HC; Fisher DA; Krishnan P; Hsu LY
    Clin Microbiol Infect; 2012 May; 18(5):502-8. PubMed ID: 21851482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.
    Thaden JT; Li Y; Ruffin F; Maskarinec SA; Hill-Rorie JM; Wanda LC; Reed SD; Fowler VG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study.
    Vallejo-Torres L; Pujol M; Shaw E; Wiegand I; Vigo JM; Stoddart M; Grier S; Gibbs J; Vank C; Cuperus N; van den Heuvel L; Eliakim-Raz N; Carratala J; Vuong C; MacGowan A; Babich T; Leibovici L; Addy I; Morris S;
    BMJ Open; 2018 Apr; 8(4):e020251. PubMed ID: 29654026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.
    Hawkey PM; Warren RE; Livermore DM; McNulty CAM; Enoch DA; Otter JA; Wilson APR
    J Antimicrob Chemother; 2018 Mar; 73(suppl_3):iii2-iii78. PubMed ID: 29514274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.
    MacVane SH
    J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.